Results 221 to 230 of about 227,240 (251)

Immune Checkpoint Inhibition

2018
Immune checkpoint inhibitors (ICI) represent a class of immuno-oncology drugs consisting of monoclonal antibodies occurring against inhibitory receptors or ligands within the immune system including CTLA-4, PD-1, and PD-L1. ICI has transformed oncology in the last decade leading to increased response rates and improved overall survival across several ...
Sarah Sammons, Megan McNamara, April K. S. Salama, Jeffrey Crawford   +3 more
openaire   +1 more source

Immune checkpoint inhibitors

Reactions Weekly, 2020
  +5 more sources

Checkpoints in antibacterial immunity

Research in Immunology, 1998
Flesch, I., Collins, H., Hess, J., Kaufmann, S.   +3 more
openaire   +3 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Priscilla K Brastianos   +2 more
exaly  

Immune Checkpoint Inhibitors

2022
Keith C. K. Lau, Benson Weyant, Carlos Cervera   +2 more
openaire   +1 more source

Immune Checkpoints

2019
Sylvia Lee, Shailender Bhatia
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Immune Checkpoint Inhibition

2023
James Isaacs, Afreen Shariff, Jeffrey Crawford   +2 more
openaire   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly